Revisiting the ALA/N (α-Lipoic Acid/Low-Dose Naltrexone) Protocol for People With Metastatic and Nonmetastatic Pancreatic Cancer: A Report of 3 New Cases - 0 views
-
Nathan Goodyear on 08 Sep 14Case study of 3 patients with Pancreatic cancer treated with IV alpha lipoic acid and LDN therapy. This is a f/u to a patient treated and still living--case study published in '06. Only, the abstract is currently available to the general public.